1. Home
  2. DGHI vs ADAG Comparison

DGHI vs ADAG Comparison

Compare DGHI & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGHI
  • ADAG
  • Stock Information
  • Founded
  • DGHI 2017
  • ADAG 2011
  • Country
  • DGHI United States
  • ADAG China
  • Employees
  • DGHI N/A
  • ADAG N/A
  • Industry
  • DGHI Finance: Consumer Services
  • ADAG Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGHI Finance
  • ADAG Health Care
  • Exchange
  • DGHI Nasdaq
  • ADAG Nasdaq
  • Market Cap
  • DGHI 90.1M
  • ADAG 81.9M
  • IPO Year
  • DGHI N/A
  • ADAG 2021
  • Fundamental
  • Price
  • DGHI $2.63
  • ADAG $1.76
  • Analyst Decision
  • DGHI Strong Buy
  • ADAG Strong Buy
  • Analyst Count
  • DGHI 1
  • ADAG 1
  • Target Price
  • DGHI $2.50
  • ADAG $8.00
  • AVG Volume (30 Days)
  • DGHI 1.0M
  • ADAG 153.3K
  • Earning Date
  • DGHI 04-02-2025
  • ADAG 03-09-2025
  • Dividend Yield
  • DGHI N/A
  • ADAG N/A
  • EPS Growth
  • DGHI N/A
  • ADAG N/A
  • EPS
  • DGHI N/A
  • ADAG N/A
  • Revenue
  • DGHI $42,146,057.00
  • ADAG $815,746.00
  • Revenue This Year
  • DGHI N/A
  • ADAG N/A
  • Revenue Next Year
  • DGHI N/A
  • ADAG $2.70
  • P/E Ratio
  • DGHI N/A
  • ADAG N/A
  • Revenue Growth
  • DGHI 100.56
  • ADAG N/A
  • 52 Week Low
  • DGHI $0.84
  • ADAG $1.64
  • 52 Week High
  • DGHI $3.77
  • ADAG $3.65
  • Technical
  • Relative Strength Index (RSI)
  • DGHI 49.56
  • ADAG 42.36
  • Support Level
  • DGHI $2.81
  • ADAG $1.64
  • Resistance Level
  • DGHI $3.48
  • ADAG $1.95
  • Average True Range (ATR)
  • DGHI 0.46
  • ADAG 0.10
  • MACD
  • DGHI -0.06
  • ADAG 0.00
  • Stochastic Oscillator
  • DGHI 10.24
  • ADAG 37.50

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: